Acupuncture and moxibustion in the treatment of ulcerative colitis: A randomized controlled study

References

• Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 1998; 280: 1569–75
   PubMed Web of Science ®Google Scholar
• Pelletier KR, Astin JA. Integration and reimbursement of complementary and alternative medicine by managed care and insurance providers: 2000 update and cohort analysis. Altern Ther Health Med 2002; 8: 44–38–9, 42
   Google Scholar
• Hilsden RJ, Verhoef MJ, Best A, Pocobelli G. Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey. Am J Gastroenterol 2003; 98: 1563–8
   PubMed Web of Science ®Google Scholar
• Rawsthorne P, Shanahan F, Cronin NC, Anton PA, Lofberg R, Bohman L, et al. An international survey of the use and attitudes regarding alternative medicine by patients with inflammatory bowel disease. Am J Gastroenterol 1999; 94: 1298–303
   PubMed Web of Science ®Google Scholar
• Joos S, Hahn EG, Brinkhaus B. Use of complementary medicine: a survey in patients with inflammatory bowel disease. Z Allg Med 2005; 81: 32
   Google Scholar
• Xinnong C. Chinese acupuncture and moxibustion2nd ed. Foreign Languages Press, BeijingChina 1990
   Google Scholar
• Macioca G. The practice of Chinese medicine1st ed. Churchill Livingstone, New York 1994
   Google Scholar
• Chen Z. Treatment of ulcerative colitis with acupuncture. J Trad Chin Med 1995; 15: 231–3
   PubMedGoogle Scholar
• Zhang X. Twenty-three cases of chronic nonspecific ulcerative colitis treated by acupuncture and moxibustion. J Trad Chin Med 1998; 18: 188–91
   PubMedGoogle Scholar
• Yang C, Yan H. Observation of the efficacy of acupuncture and moxibustion in 62 cases of chronic colitis. J Trad Chin Med 1999; 19: 111–4
   PubMedGoogle Scholar
• Joos S, Brinkhaus B, Maluche C, Maupai N, Kohnen R, Kraehmer N, et al. Acupuncture and moxibustion in the treatment of active Crohn's disease: a randomized controlled study. Digestion 2004; 69: 131–9
   PubMed Web of Science ®Google Scholar
• Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. Br Med J 1989; 298: 82–6
   PubMed Web of Science ®Google Scholar
• Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, Braakman T, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 1997; 337: 1029–35
   PubMed Web of Science ®Google Scholar
• Andus T, Klebl F, Rogler G, Bregenzer N, Scholmerich J, Straub RH. Patients with refractory Crohn's disease or ulcerative colitis respond to dehydroepiandrosterone: a pilot study. Aliment Pharmacol Ther 2003; 17: 409–14
   PubMed Web of Science ®Google Scholar
• Pallis AG, Mouzas IA, Vlachonikolis IG. The inflammatory bowel disease questionnaire: a review of its national validation studies. Inflamm Bowel Dis 2004; 10: 261–9
   PubMed Web of Science ®Google Scholar
• Rose M, Fliege H, Hildebrandt M, Korber J, Arck P, Dignass A, et al. Validation of the new German translation version of the “Short Inflammatory Bowel Disease Questionnaire” (SIBDQ)]. Z Gastroenterol 2000; 38: 277–86
   PubMed Web of Science ®Google Scholar
• Chambers RE, Stross P, Barry RE, Whicher JT. Serum amyloid A protein compared with C-reactive protein, alpha 1-antichymotrypsin and alpha 1-acid glycoprotein as a monitor of inflammatory bowel disease. Eur J Clin Invest 1987; 17: 460–7
   PubMed Web of Science ®Google Scholar
• Shine B, Berghouse L, Jones JE, Landon J. C-reactive protein as an aid in the differentiation of functional and inflammatory bowel disorders. Clin Chim Acta 1985; 148: 105–9
   PubMed Web of Science ®Google Scholar
• Linde K, Dincer F. How informed is consent in sham-controlled trials of acupuncture?. J Altern Complement Med 2004; 10: 379–85
   PubMed Web of Science ®Google Scholar
• Vickers AJ. Placebo controls in randomized trials of acupuncture. Eval Health Prof 2002; 25: 421–35
   PubMed Web of Science ®Google Scholar
• Vincent C, Lewith G. Placebo controls for acupuncture studies. J R Soc Med 1995; 88: 199–202
   PubMed Web of Science ®Google Scholar
• Zaslawski C, Rogers C, Garvey M, Ryan D, Yang CX, Zhang SP. Strategies to maintain the credibility of sham acupuncture used as a control treatment in clinical trials. J Altern Complement Med 1997; 3: 257–66
   PubMedGoogle Scholar
• Cohen, J. Statistical power analysis for the behavioral sciences. New York: Academic Press; 1988.
   Google Scholar
• Schouten HJ. Adaptive biased urn randomization in small strata when blinding is impossible. Biometrics 1995; 51: 1529–35
   PubMed Web of Science ®Google Scholar
• Summers RW, Switz DM, Sessions JT, Jr, Becktel JM, Best WR, Kern F, Jr, et al. National Cooperative Crohn's Disease Study: results of drug treatment. Gastroenterology 1979; 77: 847–69
   PubMed Web of Science ®Google Scholar
• Greenberg GR, Feagan BG, Martin F, Sutherland LR, Thomson AB, Williams CN, et al. Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group. Gastroenterology 1996; 110: 45–51
   PubMed Web of Science ®Google Scholar
• Ilnyckyj A, Shanahan F, Anton PA, Cheang M, Bernstein CN. Quantification of the placebo response in ulcerative colitis. Gastroenterology 1997; 112: 1854–8
   PubMed Web of Science ®Google Scholar
• Bebb JR, Scott BB. How effective are the usual treatments for ulcerative colitis?. Aliment Pharmacol Ther 2004; 20: 143–9
   PubMed Web of Science ®Google Scholar
• Anton PA, Shanahan F. Neuroimmunomodulation in inflammatory bowel disease. How far from “bench” to “bedside”?. Ann NY Acad Sci 1998; 840: 723–34
   PubMed Web of Science ®Google Scholar
• Chaput de Saintonge DM, Herxheimer A. Harnessing placebo effects in health care. Lancet 1994; 344: 995–8
   PubMed Web of Science ®Google Scholar
• Paterson C, Dieppe P. Characteristic and incidental (placebo) effects in complex interventions such as acupuncture. Br Med J 2005; 330: 1202–5
   PubMed Web of Science ®Google Scholar
• Mawdsley JE, Rampton DS. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut 2005; 54: 1481–91
   PubMed Web of Science ®Google Scholar
• Mayer EA. The neurobiology of stress and gastrointestinal disease. Gut 2000; 47: 861–9
   PubMed Web of Science ®Google Scholar
• Lundeberg T, Eriksson SV, Theodorsson E. Neuroimmunomodulatory effects of acupuncture in mice. Neurosci Lett 1991; 128: 161–4
   PubMed Web of Science ®Google Scholar
• Ouyang H, Chen JD. Review article: therapeutic roles of acupuncture in functional gastrointestinal disorders. Aliment Pharmacol Ther 2004; 20: 831–41
   PubMed Web of Science ®Google Scholar
• Wu HG, Zhou LB, Shi DR, Liu SM, Liu HR, Zhang BM, et al. Morphological study on colonic pathology in ulcerative colitis treated by moxibustion. World J Gastroenterol 2000; 6: 861–5
   PubMed Web of Science ®Google Scholar
• Wu HG, Zhou LB, Pan YY, Huang C, Chen HP, Shi Z, et al. Study of the mechanisms of acupuncture and moxibustion treatment for ulcerative colitis rats in view of the gene expression of cytokines. World J Gastroenterol 1999; 5: 515–7
   PubMed Web of Science ®Google Scholar
• Wu HG, Gong X, Yao LQ, Zhang W, Shi Y, Liu HR, et al. Mechanisms of acupuncture and moxibustion in regulation of epithelial cell apoptosis in rat ulcerative colitis. World J Gastroenterol 2004; 10: 682–8
   PubMed Web of Science ®Google Scholar
• Wu B. Effect of acupuncture on the regulation of cell-mediated immunity in the patients with malignant tumors. Zhen Ci Yan Jiu 1995; 20: 67–71
   PubMedGoogle Scholar
• Joos S, Schott C, Zou H, Daniel V, Martin E. Immunomodulatory effects of acupuncture in the treatment of allergic asthma: a randomized controlled study. J Altern Complement Med 2000; 6: 519–25
   PubMed Web of Science ®Google Scholar
• Paterson C, Britten N. Acupuncture as a complex intervention: a holistic model. J Altern Complement Med 2004; 10: 791–801
   PubMed Web of Science ®Google Scholar
• Ochsenkuhn T, Sackmann M, Goke B. Infliximab for acute, not steroid-refractory ulcerative colitis: a randomized pilot study. Eur J Gastroenterol Hepatol 2004; 16: 1167–71
   PubMed Web of Science ®Google Scholar
• Kurtovic J, Segal I. Recent advances in biological therapy for inflammatory bowel disease. Trop Gastroenterol 2004; 25: 9–14
   PubMedGoogle Scholar
• Jarnerot G, Hertervig E, Friis-Liby I, Blomquist L, Karlen P, Granno C, et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology 2005; 128: 1805–11
   PubMed Web of Science ®Google Scholar